Filing identity and reporting period
Important identity mismatch: The supplied filing is for Ecology Coatings, Inc., not ABVC Biopharma, Inc. It is a Form 10-Q for the quarter ended December 31, 2013, although the request metadata identifies “2014 Q1.” The report was signed April 17, 2015, and states the financial statements are unaudited.
The company says it filed for Chapter 7 bankruptcy in May 2013 and later emerged on September 19, 2014, with liabilities settled and only its corporate shell remaining. It describes the reported operating results as no longer applicable to the post-bankruptcy company. The filing contains conflicting bankruptcy dates in different sections, including a reference to May 15, 2012.
Financial results and condition
Amounts below are in dollars unless otherwise stated.
| Metric | Quarter ended Dec. 31, 2013 | Quarter ended Dec. 31, 2012 |
|---|---|---|
| Revenue | $0 | $7,026 |
| Operating expenses | $10 | $144,460 |
| Operating loss | $(10) | $(137,434) |
| Interest expense | $0 | $(16,369) |
| Net loss | $(10) | $(153,803) |
| Net loss available to common shareholders | $(10) | $(157,151) |
| Net cash used in operating activities | $(10) | $(36,350) |
| Ending cash | $608 | $2,036 |
At December 31, 2013, total assets were $231,959, including cash of $608, accounts receivable of $1,238, property and equipment of $37,249, and intangible assets of $192,864. Total liabilities subject to compromise were $2,112,143; reported equity was a deficit of $1,880,184. The filing states the company had working-capital deficits and negative cash flows. It does not provide a clear breakdown of current liabilities or a debt maturity schedule.
No revenue or margin was generated in the 2013 quarter. The filing provides no guidance or quantified outlook.
Changes, commentary, and risks
- Revenue fell to zero from $7,026. Management attributed the substantially lower operating expenses and the absence of interest expense to reduced staffing, lower professional fees, and the company operating in bankruptcy proceedings.
- Cash declined by $10 during the quarter, from $618 to $608. The prior-year quarter ended with $2,036 of cash and used $36,350 in operating activities.
- The company reported no income-tax provision, explaining that deferred tax assets associated with net operating losses were fully reserved.
- Management identified risks including the ability to establish a new business plan, raise capital, meet filing obligations, commercialize technology, generate revenue, and compete. It also cited risks involving intellectual property, suppliers, manufacturing capability, staffing, and general economic conditions.
- Disclosure controls and procedures were reported ineffective because the small finance staff resulted in a lack of segregation of duties. The filing says transactions during bankruptcy were subject to trustee supervision and court approval.
- The filing reports no commitments or contingencies in its note, while also describing Chapter 7 liquidation and liabilities that could be compromised. It states the shell emerged in September 2014 with liabilities settled; the timing and presentation of these events relative to the December 2013 statements warrant review.
Key facts for investors to verify
- Confirm the intended issuer and period: this filing identifies Ecology Coatings, Inc. and the quarter ended December 31, 2013, not ABVC Biopharma or 2014 Q1.
- Reconcile the bankruptcy filing date: the report gives both May 15, 2013 and May 15, 2012 in different passages, and describes the bankruptcy chronology inconsistently.
- Verify the post-bankruptcy status, debt settlement, and “fresh start” accounting treatment, including how these events affect the reported liabilities and assets.
- Investigate equity-share disclosures: the balance sheet shows common shares increasing from 14,158,506 at September 30 to 54,593,032 at December 31, while a note says no shares were issued during the quarter.
- Review the going-concern and liquidity position, the stated ineffective disclosure controls, and the company’s capacity to fund continued reporting or any future business plan.